US Stock MarketDetailed Quotes

Dyne Therapeutics (DYN)

Watchlist
  • 16.420
  • -1.030-5.90%
Close Jan 15 15:59 ET
2.66BMarket Cap-4.54P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dyne Therapeutics (DYN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
7.79%113.89M
60.91%115.79M
76.95%122.37M
42.01%343.89M
43.46%97.11M
69.67%105.66M
7.83%71.96M
52.11%69.16M
41.65%242.16M
68.61%67.69M
Selling and administrative expenses
29.66%16.67M
70.69%16.56M
-35.31%15.93M
98.98%62.48M
73.03%15.3M
83.12%12.86M
27.52%9.7M
210.52%24.62M
11.34%31.4M
27.16%8.84M
-General and administrative expense
29.66%16.67M
70.69%16.56M
-35.31%15.93M
98.98%62.48M
73.03%15.3M
83.12%12.86M
27.52%9.7M
210.52%24.62M
11.34%31.4M
27.16%8.84M
Research and development costs
4.76%97.22M
59.38%99.24M
139.00%106.45M
33.52%281.41M
39.02%81.81M
67.96%92.8M
5.30%62.26M
18.66%44.54M
47.63%210.76M
77.29%58.84M
Operating profit
-7.79%-113.89M
-60.91%-115.79M
-76.95%-122.37M
-42.01%-343.89M
-43.46%-97.11M
-69.67%-105.66M
-7.83%-71.96M
-52.11%-69.16M
-41.65%-242.16M
-68.61%-67.69M
Net non-operating interest income expense
-39.93%5.57M
-7.39%6.53M
136.51%7.1M
252.34%26.92M
333.58%7.59M
323.76%9.28M
219.53%7.05M
101.07%3M
161.95%7.64M
30.48%1.75M
Non-operating interest income
-8.62%8.48M
-6.06%6.63M
136.51%7.1M
252.34%26.92M
333.58%7.59M
323.76%9.28M
219.53%7.05M
101.07%3M
161.95%7.64M
30.48%1.75M
Non-operating interest expense
--2.9M
--94K
----
----
----
--0
--0
----
----
----
Other net income (expense)
137.60%279K
-731.77%-1.6M
-117.59%-89K
67.94%-454K
96.29%-26K
-488.89%-742K
48.53%-192K
334.26%506K
-2,522.22%-1.42M
-2,820.83%-701K
Other non- operating income (expenses)
137.60%279K
-731.77%-1.6M
-117.59%-89K
67.94%-454K
96.29%-26K
-488.89%-742K
48.53%-192K
334.26%506K
-2,522.22%-1.42M
-2,820.83%-701K
Income before tax
-11.24%-108.04M
-70.28%-110.86M
-75.72%-115.36M
-34.54%-317.42M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.1M
-48.57%-65.65M
-40.36%-235.94M
-71.63%-66.64M
Income tax
Net income
-11.24%-108.04M
-70.28%-110.86M
-75.72%-115.36M
-34.54%-317.42M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.1M
-48.57%-65.65M
-40.36%-235.94M
-71.63%-66.64M
Net income continuous Operations
-11.24%-108.04M
-70.28%-110.86M
-75.72%-115.36M
-34.54%-317.42M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.1M
-48.57%-65.65M
-40.36%-235.94M
-71.63%-66.64M
Minority interest income
Net income attributable to the parent company
-11.24%-108.04M
-70.28%-110.86M
-75.72%-115.36M
-34.54%-317.42M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.1M
-48.57%-65.65M
-40.36%-235.94M
-71.63%-66.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-11.24%-108.04M
-70.28%-110.86M
-75.72%-115.36M
-34.54%-317.42M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.1M
-48.57%-65.65M
-40.36%-235.94M
-71.63%-66.64M
Basic earnings per share
20.83%-0.76
-38.57%-0.97
-29.63%-1.05
14.68%-3.37
19.27%-0.88
3.03%-0.96
35.19%-0.7
-3.85%-0.81
-22.29%-3.95
-47.30%-1.09
Diluted earnings per share
20.83%-0.76
-38.57%-0.97
-29.63%-1.05
14.68%-3.37
19.27%-0.88
3.03%-0.96
35.19%-0.7
-3.85%-0.81
-22.29%-3.95
-47.30%-1.09
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 7.79%113.89M60.91%115.79M76.95%122.37M42.01%343.89M43.46%97.11M69.67%105.66M7.83%71.96M52.11%69.16M41.65%242.16M68.61%67.69M
Selling and administrative expenses 29.66%16.67M70.69%16.56M-35.31%15.93M98.98%62.48M73.03%15.3M83.12%12.86M27.52%9.7M210.52%24.62M11.34%31.4M27.16%8.84M
-General and administrative expense 29.66%16.67M70.69%16.56M-35.31%15.93M98.98%62.48M73.03%15.3M83.12%12.86M27.52%9.7M210.52%24.62M11.34%31.4M27.16%8.84M
Research and development costs 4.76%97.22M59.38%99.24M139.00%106.45M33.52%281.41M39.02%81.81M67.96%92.8M5.30%62.26M18.66%44.54M47.63%210.76M77.29%58.84M
Operating profit -7.79%-113.89M-60.91%-115.79M-76.95%-122.37M-42.01%-343.89M-43.46%-97.11M-69.67%-105.66M-7.83%-71.96M-52.11%-69.16M-41.65%-242.16M-68.61%-67.69M
Net non-operating interest income expense -39.93%5.57M-7.39%6.53M136.51%7.1M252.34%26.92M333.58%7.59M323.76%9.28M219.53%7.05M101.07%3M161.95%7.64M30.48%1.75M
Non-operating interest income -8.62%8.48M-6.06%6.63M136.51%7.1M252.34%26.92M333.58%7.59M323.76%9.28M219.53%7.05M101.07%3M161.95%7.64M30.48%1.75M
Non-operating interest expense --2.9M--94K--------------0--0------------
Other net income (expense) 137.60%279K-731.77%-1.6M-117.59%-89K67.94%-454K96.29%-26K-488.89%-742K48.53%-192K334.26%506K-2,522.22%-1.42M-2,820.83%-701K
Other non- operating income (expenses) 137.60%279K-731.77%-1.6M-117.59%-89K67.94%-454K96.29%-26K-488.89%-742K48.53%-192K334.26%506K-2,522.22%-1.42M-2,820.83%-701K
Income before tax -11.24%-108.04M-70.28%-110.86M-75.72%-115.36M-34.54%-317.42M-34.37%-89.54M-61.31%-97.13M-0.31%-65.1M-48.57%-65.65M-40.36%-235.94M-71.63%-66.64M
Income tax
Net income -11.24%-108.04M-70.28%-110.86M-75.72%-115.36M-34.54%-317.42M-34.37%-89.54M-61.31%-97.13M-0.31%-65.1M-48.57%-65.65M-40.36%-235.94M-71.63%-66.64M
Net income continuous Operations -11.24%-108.04M-70.28%-110.86M-75.72%-115.36M-34.54%-317.42M-34.37%-89.54M-61.31%-97.13M-0.31%-65.1M-48.57%-65.65M-40.36%-235.94M-71.63%-66.64M
Minority interest income
Net income attributable to the parent company -11.24%-108.04M-70.28%-110.86M-75.72%-115.36M-34.54%-317.42M-34.37%-89.54M-61.31%-97.13M-0.31%-65.1M-48.57%-65.65M-40.36%-235.94M-71.63%-66.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -11.24%-108.04M-70.28%-110.86M-75.72%-115.36M-34.54%-317.42M-34.37%-89.54M-61.31%-97.13M-0.31%-65.1M-48.57%-65.65M-40.36%-235.94M-71.63%-66.64M
Basic earnings per share 20.83%-0.76-38.57%-0.97-29.63%-1.0514.68%-3.3719.27%-0.883.03%-0.9635.19%-0.7-3.85%-0.81-22.29%-3.95-47.30%-1.09
Diluted earnings per share 20.83%-0.76-38.57%-0.97-29.63%-1.0514.68%-3.3719.27%-0.883.03%-0.9635.19%-0.7-3.85%-0.81-22.29%-3.95-47.30%-1.09
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -